By Michael Manuel, MD
Wound Care, Wound Care Solutions

Effective wound management is critical to patient care in modern hospital settings, particularly for individuals suffering from chronic, non-healing, or complex wounds. Among the advanced therapies now integrated into wound care programs, hyperbaric oxygen therapy (HBOT) has emerged as a valuable and evidence-based option. Delivered in a hyperbaric chamber, this treatment provides patients with 100 percent oxygen at pressures greater than normal atmospheric levels, creating physiological effects that enhance healing and improve outcomes in a hospital environment.

One of HBOT's primary benefits is its ability to significantly increase the amount of oxygen dissolved in a patient's blood plasma. In wounds where circulation is compromised—such as diabetic foot ulcers, radiation-induced tissue damage, or post-surgical complications—the oxygen supply to the affected area is insufficient for routine healing. Exposing patients to high-pressure oxygen, HBOT promotes oxygen diffusion into tissues that otherwise receive inadequate perfusion. This surplus oxygen stimulates angiogenesis, the development of new blood vessels, and helps restore circulation to damaged tissue.

Another critical advantage of HBOT is its ability to fight infection. Many chronic wounds are complicated by bacterial contamination and, in some cases, aggressive anaerobic infections. Oxygen at high partial pressures has direct bactericidal effects on specific organisms and enhances the effectiveness of white blood cells in fighting infection. Additionally, HBOT can improve the efficacy of certain antibiotics, creating a synergistic effect that reduces bacterial load and supports the body's natural immune response. This makes it particularly effective in managing wounds complicated by osteomyelitis or necrotizing infections.

Hospitals incorporating HBOT into wound care protocols also benefit from reduced amputation rates and improved functional recovery. For patients with diabetic foot ulcers, for example, studies have shown that HBOT can lower the likelihood of major amputations by supporting wound closure and tissue viability. The ability to save a limb improves patient quality of life and reduces long-term healthcare costs associated with prosthetics, rehabilitation, and disability care.

Moreover, HBOT contributes to improved tissue repair by influencing cellular activity. High oxygen levels enhance fibroblast function and collagen synthesis, which are essential for wound closure. They also stimulate the release of growth factors and stem cells that further accelerate repair. In compromised skin grafts or flaps, HBOT has enhanced survival rates, ensuring better surgical outcomes and reducing the need for repeat interventions.

HBOT also complements multidisciplinary wound care programs in a hospital setting, providing physicians, nurses, and specialists with another powerful tool to address complex cases. The treatment is non-invasive, well-tolerated by most patients, and can be integrated seamlessly into inpatient or outpatient care plans. Hospitals that offer HBOT expand their therapeutic options and are committed to comprehensive, state-of-the-art wound management.

In summary, hyperbaric oxygen therapy significantly advances hospital-based wound care. By increasing oxygen delivery, enhancing infection control, reducing amputation rates, and promoting faster tissue repair, HBOT has established itself as a safe and effective adjunct to traditional wound care practices. As the demand for innovative, outcome-driven treatments continues to grow, the hyperbaric chamber is essential for improving patient recovery and quality of life.